Kymera Therapeutics, Inc.
Ticker: KYMR
| Insider | Title |
|---|---|
| Bros. Advisors (gp) Llc Baker | Director |
| Bros. Advisors Lp Baker | Director |
| Brothers Life Sciences Lp Baker | Director |
| Bruce Booth | Director |
| Bruce N. Jacobs | Chief Financial Officer |
| Donald William Nicholson | Director |
| Elaine Caughey | Chief Business Officer |
| Elena Ridloff | Director |
| Ellen Chiniara | Chief Legal Officer |
| Felix Baker | Director |
| Gorjan Hrustanovic | Director |
| Gp Holdings Llc Bvf | Director, See Remarks and Footnotes |
| I Gp Llc Bvf | Director, See Remarks and Footnotes |
| Ii Gp Llc Bvf | Director, See Remarks and Footnotes |
| Inc/il Bvf | Director, See Remarks and Footnotes |
| Jared Gollob | Chief Medical Officer |
| Jeffrey W. Albers | Director |
| Jeremy G Chadwick | Chief Operating Officer |
| Joanna Horobin | Director |
| John Maraganore | Director |
| Julian Baker | Director |
| L.p. 667, | Director |
| Leigh Morgan | Director |
| Mark N Lampert | Director, See Remarks and Footnotes |
| Nello Mainolfi | Chief Executive Officer, Director |
| Pamela Esposito | Director |
| Partners L P/il Bvf | Director, See Remarks and Footnotes |
| Partners Os Ltd. Bvf | Director, See Remarks and Footnotes |
| Richard Chesworth | Chief Scientific Officer |
| Steven Edward Hall | Director |
| Value Fund Ii Lp Biotechnology | Director, See Remarks and Footnotes |
| Value Fund L P Biotechnology | Director, See Remarks and Footnotes |
| Value Trading Fund Os Lp Biotechnology | Director, See Remarks and Footnotes |
| Venture Associates Opportunity I, L.p. Atlas | 10% or greater ownership |
| Venture Associates Opportunity I, Llc Atlas | 10% or greater ownership |
| Venture Associates X, L.p. Atlas | 10% or greater ownership |
| Venture Associates X, Llc Atlas | 10% or greater ownership |
| Venture Fund X, L.p. Atlas | 10% or greater ownership |
| Venture Opportunity Fund I, L.p. Atlas | 10% or greater ownership |
| Victor Sandor | Director |